BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23514599)

  • 1. GC-targeted C8-linked pyrrolobenzodiazepine-biaryl conjugates with femtomolar in vitro cytotoxicity and in vivo antitumor activity in mouse models.
    Rahman KM; Jackson PJ; James CH; Basu BP; Hartley JA; de la Fuente M; Schatzlein A; Robson M; Pedley RB; Pepper C; Fox KR; Howard PW; Thurston DE
    J Med Chem; 2013 Apr; 56(7):2911-35. PubMed ID: 23514599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Systematic Shortening of Noncovalent C8 Side Chain on the Cytotoxicity and NF-κB Inhibitory Capacity of Pyrrolobenzodiazepines (PBDs).
    Corcoran DB; Lewis T; Nahar KS; Jamshidi S; Fegan C; Pepper C; Thurston DE; Rahman KM
    J Med Chem; 2019 Feb; 62(4):2127-2139. PubMed ID: 30688457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents.
    Kamal A; Vijaya Bharathi E; Janaki Ramaiah M; Dastagiri D; Surendranadha Reddy J; Viswanath A; Sultana F; Pushpavalli SN; Pal-Bhadra M; Srivastava HK; Narahari Sastry G; Juvekar A; Sen S; Zingde S
    Bioorg Med Chem; 2010 Jan; 18(2):526-42. PubMed ID: 20031423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linker length modulates DNA cross-linking reactivity and cytotoxic potency of C8/C8' ether-linked C2-exo-unsaturated pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimers.
    Gregson SJ; Howard PW; Gullick DR; Hamaguchi A; Corcoran KE; Brooks NA; Hartley JA; Jenkins TC; Patel S; Guille MJ; Thurston DE
    J Med Chem; 2004 Feb; 47(5):1161-74. PubMed ID: 14971896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of C8-linked pyrrolo[2,1-c][1,4]benzodiazepine-benzimidazole conjugates with remarkable DNA-binding affinity.
    Kamal A; Ramulu P; Srinivas O; Ramesh G; Kumar PP
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4791-4. PubMed ID: 15324909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of pyrrolo[2,1-c][1,4]benzodiazepine (PBD) C8 cyclic amine conjugates.
    Masterson LA; Croker SJ; Jenkins TC; Howard PW; Thurston DE
    Bioorg Med Chem Lett; 2004 Feb; 14(4):901-4. PubMed ID: 15012990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anticancer activity of chalcone-pyrrolobenzodiazepine conjugates linked via 1,2,3-triazole ring side-armed with alkane spacers.
    Kamal A; Prabhakar S; Janaki Ramaiah M; Venkat Reddy P; Ratna Reddy Ch; Mallareddy A; Shankaraiah N; Lakshmi Narayan Reddy T; Pushpavalli SN; Pal-Bhadra M
    Eur J Med Chem; 2011 Sep; 46(9):3820-31. PubMed ID: 21676506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, DNA-binding ability and evaluation of antitumour activity of triazolo[1,2,4]benzothiadiazine linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates.
    Kamal A; Khan MN; Srikanth YV; Reddy KS; Juvekar A; Sen S; Kurian N; Zingde S
    Bioorg Med Chem; 2008 Aug; 16(16):7804-10. PubMed ID: 18657979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biophysical and biological evaluation of a series of pyrrolobenzodiazepine-poly(N-methylpyrrole) conjugates.
    Wells G; Martin CR; Howard PW; Sands ZA; Laughton CA; Tiberghien A; Woo CK; Masterson LA; Stephenson MJ; Hartley JA; Jenkins TC; Shnyder SD; Loadman PM; Waring MJ; Thurston DE
    J Med Chem; 2006 Sep; 49(18):5442-61. PubMed ID: 16942018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase synthesis of new pyrrolobenzodiazepine-chalcone conjugates: DNA-binding affinity and anticancer activity.
    Kamal A; Shankaraiah N; Prabhakar S; Reddy ChR; Markandeya N; Reddy KL; Devaiah V
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2434-9. PubMed ID: 18325766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dithiocarbamate/piperazine bridged pyrrolobenzodiazepines as DNA-minor groove binders: synthesis, DNA-binding affinity and cytotoxic activity.
    Kamal A; Sreekanth K; Shankaraiah N; Sathish M; Nekkanti S; Srinivasulu V
    Bioorg Chem; 2015 Apr; 59():23-30. PubMed ID: 25665519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An extended pyrrolobenzodiazepine-polyamide conjugate with selectivity for a DNA sequence containing the ICB2 transcription factor binding site.
    Brucoli F; Hawkins RM; James CH; Jackson PJ; Wells G; Jenkins TC; Ellis T; Kotecha M; Hochhauser D; Hartley JA; Howard PW; Thurston DE
    J Med Chem; 2013 Aug; 56(16):6339-51. PubMed ID: 23889553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and evaluation of new noncross-linking pyrrolobenzodiazepine dimers with efficient DNA binding ability and potent antitumor activity.
    Kamal A; Ramesh G; Laxman N; Ramulu P; Srinivas O; Neelima K; Kondapi AK; Sreenu VB; Nagarajaram HA
    J Med Chem; 2002 Oct; 45(21):4679-88. PubMed ID: 12361394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in novel pyrrolo[2,1-c][1,4]benzodiazepine conjugates: synthesis and biological evaluation.
    Kumar R; Lown JW
    Mini Rev Med Chem; 2003 Jun; 3(4):323-39. PubMed ID: 12678826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel polyamide-pyrrolobenzodiazepine hybrids for antibody-drug conjugates.
    Thomas JD; Yurkovetskiy AV; Yin M; Bodyak ND; Gumerov DR; Tang S; Kelleher E; Jones BD; Protopopova M; Qin L; Uttard A; Demady DR; Lowinger TB
    Bioorg Med Chem Lett; 2022 Sep; 72():128876. PubMed ID: 35788036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and evaluation of a novel sequence-selective epoxide-containing DNA cross-linking agent based on the pyrrolo[2, 1-c][1,4]benzodiazepine system.
    Wilson SC; Howard PW; Forrow SM; Hartley JA; Adams LJ; Jenkins TC; Kelland LR; Thurston DE
    J Med Chem; 1999 Oct; 42(20):4028-41. PubMed ID: 10514273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies.
    Flynn MJ; Zammarchi F; Tyrer PC; Akarca AU; Janghra N; Britten CE; Havenith CE; Levy JN; Tiberghien A; Masterson LA; Barry C; D'Hooge F; Marafioti T; Parren PW; Williams DG; Howard PW; van Berkel PH; Hartley JA
    Mol Cancer Ther; 2016 Nov; 15(11):2709-2721. PubMed ID: 27535974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C8-Linked Pyrrolobenzodiazepine Monomers with Inverted Building Blocks Show Selective Activity against Multidrug Resistant Gram-Positive Bacteria.
    Andriollo P; Hind CK; Picconi P; Nahar KS; Jamshidi S; Varsha A; Clifford M; Sutton JM; Rahman KM
    ACS Infect Dis; 2018 Feb; 4(2):158-174. PubMed ID: 29260545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloads.
    Donnell AF; Zhang Y; Stang EM; Wei DD; Tebben AJ; Perez HL; Schroeder GM; Pan C; Rao C; Borzilleri RM; Vite GD; Gangwar S
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5267-5271. PubMed ID: 29102228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of aryl-substituted naphthalene-linked pyrrolobenzodiazepine conjugates as potential anticancer agents with apoptosis-inducing ability.
    Kamal A; Reddy MK; Ramaiah MJ; Srikanth YV; Rajender ; Reddy VS; Kumar GB; Pushpavalli SN; Bag I; Juvekar A; Sen S; Zingde SM; Pal-Bhadra M
    ChemMedChem; 2011 Sep; 6(9):1665-79. PubMed ID: 21732540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.